These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30717595)

  • 21. Structural variations in the cross-beta core of amyloid beta fibrils revealed by deep UV resonance Raman spectroscopy.
    Popova LA; Kodali R; Wetzel R; Lednev IK
    J Am Chem Soc; 2010 May; 132(18):6324-8. PubMed ID: 20405832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and Dynamics of the Huntingtin Exon-1 N-Terminus: A Solution NMR Perspective.
    Baias M; Smith PE; Shen K; Joachimiak LA; Żerko S; Koźmiński W; Frydman J; Frydman L
    J Am Chem Soc; 2017 Jan; 139(3):1168-1176. PubMed ID: 28085263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation effects on structural stability of polyglutamine peptides by molecular dynamics simulation.
    Nakano M; Watanabe H; Starikov EB; Rothstein SM; Tanaka S
    Interdiscip Sci; 2009 Mar; 1(1):21-9. PubMed ID: 20640815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UV resonance Raman determination of polyproline II, extended 2.5(1)-helix, and beta-sheet Psi angle energy landscape in poly-L-lysine and poly-L-glutamic acid.
    Mikhonin AV; Myshakina NS; Bykov SV; Asher SA
    J Am Chem Soc; 2005 Jun; 127(21):7712-20. PubMed ID: 15913361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Aggregation Free Energy Landscapes of Polyglutamine Repeats.
    Chen M; Tsai M; Zheng W; Wolynes PG
    J Am Chem Soc; 2016 Nov; 138(46):15197-15203. PubMed ID: 27786478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observation of Oligomeric States Indicates a High Structural Flexibility Required for the Onset of Polyglutamine Fibrillization.
    Siu HW; Hauser K
    J Phys Chem Lett; 2022 May; 13(20):4543-4548. PubMed ID: 35580015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution structure of polyglutamine tracts in GST-polyglutamine fusion proteins.
    Masino L; Kelly G; Leonard K; Trottier Y; Pastore A
    FEBS Lett; 2002 Feb; 513(2-3):267-72. PubMed ID: 11904162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A toxic monomeric conformer of the polyglutamine protein.
    Nagai Y; Inui T; Popiel HA; Fujikake N; Hasegawa K; Urade Y; Goto Y; Naiki H; Toda T
    Nat Struct Mol Biol; 2007 Apr; 14(4):332-40. PubMed ID: 17369839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The possible structural models for polyglutamine aggregation: a molecular dynamics simulations study.
    Zhou ZL; Zhao JH; Liu HL; Wu JW; Liu KT; Chuang CK; Tsai WB; Ho Y
    J Biomol Struct Dyn; 2011 Apr; 28(5):743-58. PubMed ID: 21294586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.
    Takahashi T; Kikuchi S; Katada S; Nagai Y; Nishizawa M; Onodera O
    Hum Mol Genet; 2008 Feb; 17(3):345-56. PubMed ID: 17947294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational changes and aggregation of expanded polyglutamine proteins as therapeutic targets of the polyglutamine diseases: exposed beta-sheet hypothesis.
    Nagai Y; Popiel HA
    Curr Pharm Des; 2008; 14(30):3267-79. PubMed ID: 19075705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep UV Resonance Raman Spectroscopy for Characterizing Amyloid Aggregation.
    Handen JD; Lednev IK
    Methods Mol Biol; 2016; 1345():89-100. PubMed ID: 26453207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncoupled peptide bond vibrations in alpha-helical and polyproline II conformations of polyalanine peptides.
    Mikhonin AV; Asher SA
    J Phys Chem B; 2005 Feb; 109(7):3047-52. PubMed ID: 16851319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing polyglutamine conformation in the nucleating event by molecular dynamics simulations.
    Miettinen MS; Knecht V; Monticelli L; Ignatova Z
    J Phys Chem B; 2012 Aug; 116(34):10259-65. PubMed ID: 22770401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing the conformational ensemble of monomeric polyglutamine.
    Wang X; Vitalis A; Wyczalkowski MA; Pappu RV
    Proteins; 2006 May; 63(2):297-311. PubMed ID: 16299774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggregation kinetics of interrupted polyglutamine peptides.
    Walters RH; Murphy RM
    J Mol Biol; 2011 Sep; 412(3):505-19. PubMed ID: 21821045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative characterization of short monomeric polyglutamine peptides by replica exchange molecular dynamics simulation.
    Nakano M; Watanabe H; Rothstein SM; Tanaka S
    J Phys Chem B; 2010 May; 114(20):7056-61. PubMed ID: 20441177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and disaggregation of asparagine repeat-containing peptides.
    Lu X; Murphy RM
    J Pept Sci; 2014 Nov; 20(11):860-7. PubMed ID: 25044797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a possible amyloidogenic precursor in glutamine-repeat neurodegenerative diseases.
    Armen RS; Bernard BM; Day R; Alonso DO; Daggett V
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13433-8. PubMed ID: 16157882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the protein context on the polyglutamine length-dependent elongation of amyloid fibrils.
    Huynen C; Willet N; Buell AK; Duwez AS; Jerôme C; Dumoulin M
    Biochim Biophys Acta; 2015 Mar; 1854(3):239-48. PubMed ID: 25489872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.